Highly-purified soluble thrombomodulin and method for producing same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9127089
APP PUB NO 20130143790A1
SERIAL NO

13641047

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Highly-purified soluble thrombomodulin which has a content of host cell-originated proteins being in a ratio of less than 10 ng of the proteins per 10,000 U of the soluble thrombomodulin, wherein the soluble thrombomodulin is produced by a transformant cell obtained by transfecting a host cell with a DNA containing a nucleotide sequence encoding the soluble thrombomodulin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASAHI KASEI PHARMA CORPORATION1-1-2 YURAKUCHO CHIYODA-KU TOKYO 1000006 ?1000006

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Shigematsu, Hiroki Tokyo, JP 5 4
Ueno, Yuji Tokyo, JP 42 335

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00